Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Spyre Therapeutics Inc. (NASDAQ: SYRE) closed at $27.50 down -4.25% from its previous closing price of $28.72. In other words, the price has decreased by -$4.25 from its previous closing price. On the day, 1.05 million shares were traded. SYRE stock price reached its highest trading level at $28.95 during the session, while it also had its lowest trading level at $26.56.
Ratios:
For a deeper understanding of Spyre Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.38 and its Current Ratio is at 11.38. In the meantime, Its Debt-to-Equity ratio is 1.66 whereas as Long-Term Debt/Eq ratio is at 1.66.
On May 02, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $50.
Wells Fargo Upgraded its Equal Weight to Overweight on March 01, 2024, whereas the target price for the stock was revised from $12 to $35.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 1455838976 and an Enterprise Value of 857225664. For the stock, the TTM Price-to-Sale (P/S) ratio is 2023.84. Its current Enterprise Value per Revenue stands at 1245.968 whereas that against EBITDA is -5.87.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $47.97, while it has fallen to a 52-week low of $8.43. The 50-Day Moving Average of the stock is -9.32%, while the 200-Day Moving Average is calculated to be 4.36%.
Shares Statistics:
For the past three months, SYRE has traded an average of 619.81K shares per day and 376200 over the past ten days. A total of 50.78M shares are outstanding, with a floating share count of 46.19M. Insiders hold about 9.04% of the company’s shares, while institutions hold 64.82% stake in the company. Shares short for SYRE as of 1721001600 were 9053899 with a Short Ratio of 14.61, compared to 1718323200 on 4842295. Therefore, it implies a Short% of Shares Outstanding of 9053899 and a Short% of Float of 21.57.
